Defining Priorities for Action and Research on the Commercial Determinants of Health: A Conceptual Review.
Journal
American journal of public health
ISSN: 1541-0048
Titre abrégé: Am J Public Health
Pays: United States
ID NLM: 1254074
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
entrez:
8
12
2021
pubmed:
9
12
2021
medline:
17
12
2021
Statut:
ppublish
Résumé
In recent years, the concept of commercial determinants of health (CDoH) has attracted scholarly, public policy, and activist interest. To date, however, this new attention has failed to yield a clear and consistent definition, well-defined metrics for quantifying its impact, or coherent directions for research and intervention. By tracing the origins of this concept over 2 centuries of interactions between market forces and public health action and research, we propose an expanded framework and definition of CDoH. This conceptualization enables public health professionals and researchers to more fully realize the potential of the CDoH concept to yield insights that can be used to improve global and national health and reduce the stark health inequities within and between nations. It also widens the utility of CDoH from its main current use to study noncommunicable diseases to other health conditions such as infectious diseases, mental health conditions, injuries, and exposure to environmental threats. We suggest specific actions that public health professionals can take to transform the burgeoning interest in CDoH into meaningful improvements in health. (
Identifiants
pubmed: 34878875
doi: 10.2105/AJPH.2021.306491
pmc: PMC8667845
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2202-2211Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : CIHR
Pays : Canada
Références
Am Econ Rev. 2018 Jul;108(7):1609-58
pubmed: 30091861
Global Health. 2017 Jun 15;13(1):34
pubmed: 28619031
Am J Ind Med. 2018 Apr;61(4):277-281
pubmed: 29397007
Int J Health Policy Manag. 2021 Dec 01;10(12):784-792
pubmed: 33131225
Eur J Public Health. 2020 Aug 1;30(4):660-664
pubmed: 31953933
BMJ. 2012 Dec 17;345:e8082
pubmed: 23247988
Lancet. 2013 Feb 23;381(9867):670-9
pubmed: 23410611
PLoS One. 2018 Apr 3;13(4):e0195447
pubmed: 29614114
BMJ. 2012 Aug 21;345:e5124
pubmed: 22915664
Milbank Q. 2018 Sep;96(3):472-498
pubmed: 30277610
Annu Rev Public Health. 2014;35:385-98
pubmed: 24328986
Am J Public Health. 2018 Sep;108(9):1167-1170
pubmed: 30024808
Int J Equity Health. 2020 Jul 6;19(1):116
pubmed: 32631376
Int J Public Health. 2020 Sep;65(7):1147-1149
pubmed: 32725392
Int J Health Policy Manag. 2022 Aug 1;11(8):1251-1261
pubmed: 33619932
BMC Public Health. 2020 Jun 29;20(1):1022
pubmed: 32600398
BMJ Open. 2020 Jul 19;10(7):e034082
pubmed: 32690498
Health Promot Int. 2014 Jun;29 Suppl 1:i9-10
pubmed: 25217360
Annu Rev Sociol. 2021 Jul;47(1):131-156
pubmed: 34949900
Global Health. 2018 Feb 15;14(1):21
pubmed: 29448968
Health Promot Int. 2018 Apr 1;33(2):239-249
pubmed: 27561906
BMJ Glob Health. 2021 Feb;6(2):
pubmed: 33593758
Development (Rome). 2020;63(2-4):150-156
pubmed: 33173259
Milbank Q. 2021 Jun;99(2):503-518
pubmed: 33783862
Addiction. 2013 Apr;108(4):686-7
pubmed: 23496068
Public Health. 2017 Aug;149:120-129
pubmed: 28595064
PLoS Med. 2012;9(6):e1001235
pubmed: 22745605